Approximately 20–30% of modern pharmaceuticals and agrochemicals contain fluorine atoms, because fluorinated compounds are more difficult to oxidize, leading to increased metabolic stability and bioavailability over their non-fluorinated analogues.[1] As a consequence, rapidly increasing efforts have focused on developing valuable strategies, reagents, and catalysts for the incorporation of, for example, CF3 into various organic ...